MA32347B1 - Gelule pour la prévention de maladies cardiovasculaires - Google Patents
Gelule pour la prévention de maladies cardiovasculairesInfo
- Publication number
- MA32347B1 MA32347B1 MA33268A MA33268A MA32347B1 MA 32347 B1 MA32347 B1 MA 32347B1 MA 33268 A MA33268 A MA 33268A MA 33268 A MA33268 A MA 33268A MA 32347 B1 MA32347 B1 MA 32347B1
- Authority
- MA
- Morocco
- Prior art keywords
- prevention
- capsule
- cardiovascular disease
- coated
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne une capsule pour la prévention de maladies cardiovasculaires qui comprend des comprimés enrobés d'acide acétylsalicylique, des comprimés enrobés de simvastatine ou de pravastatine, et des comprimés enrobés de lisinopril, de ramipil ou de périndopril. Les capsules sont utilisées pour la prévention de maladies cardiovasculaires chez des populations à haut risque
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08153615 | 2008-03-28 | ||
PCT/EP2009/053545 WO2009118359A2 (fr) | 2008-03-28 | 2009-03-25 | Capsule pour la prévention de maladies cardiovasculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32347B1 true MA32347B1 (fr) | 2011-06-01 |
Family
ID=40010466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33268A MA32347B1 (fr) | 2008-03-28 | 2010-10-19 | Gelule pour la prévention de maladies cardiovasculaires |
Country Status (34)
Country | Link |
---|---|
US (1) | US8753680B2 (fr) |
EP (1) | EP2273985B1 (fr) |
JP (1) | JP2011515445A (fr) |
KR (1) | KR20110007602A (fr) |
CN (1) | CN101980701A (fr) |
AR (1) | AR071094A1 (fr) |
AU (1) | AU2009228832A1 (fr) |
BR (1) | BRPI0909254A2 (fr) |
CA (1) | CA2720800C (fr) |
CL (1) | CL2009000767A1 (fr) |
CO (1) | CO6311069A2 (fr) |
CR (1) | CR11736A (fr) |
CY (1) | CY1117556T1 (fr) |
DK (1) | DK2273985T3 (fr) |
EC (1) | ECSP10010562A (fr) |
ES (1) | ES2569553T3 (fr) |
GT (1) | GT201000275A (fr) |
HN (1) | HN2010001979A (fr) |
HR (1) | HRP20160416T1 (fr) |
HU (1) | HUE028919T2 (fr) |
IL (1) | IL208455A0 (fr) |
IS (1) | IS8932A (fr) |
MA (1) | MA32347B1 (fr) |
MX (1) | MX2010010479A (fr) |
NI (1) | NI201000159A (fr) |
NZ (1) | NZ588239A (fr) |
PL (1) | PL2273985T3 (fr) |
RU (1) | RU2477123C2 (fr) |
SI (1) | SI2273985T1 (fr) |
SV (1) | SV2010003684A (fr) |
TW (1) | TW200944251A (fr) |
UA (1) | UA99758C2 (fr) |
UY (1) | UY31741A (fr) |
WO (1) | WO2009118359A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201005325A2 (tr) * | 2010-06-30 | 2012-01-23 | Bi̇lgi̇ç Mahmut | Atorvastatin ve aspirin içeren farmasötik formülasyonlar |
FR2967577B1 (fr) * | 2010-11-18 | 2013-07-12 | Advicenne Pharma | Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament |
KR101298788B1 (ko) * | 2011-03-15 | 2013-08-22 | 보령제약 주식회사 | 안정성이 개선된 복합제제 |
KR101378973B1 (ko) * | 2012-04-13 | 2014-03-28 | 한미약품 주식회사 | 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법 |
KR20140030505A (ko) * | 2012-08-31 | 2014-03-12 | 한미약품 주식회사 | 이베살탄 및 HMG-CoA 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제 |
CN103006612B (zh) * | 2012-12-28 | 2014-07-02 | 石雷 | 一种赖诺普利迟释缓释片剂及其制备方法 |
EP2810644A1 (fr) | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Formulation orale pour le traitement de maladies cardiovasculaires |
US10411814B2 (en) * | 2015-03-05 | 2019-09-10 | Nec Corporation | Method of determining failure in radio facility and mobile radio system |
BE1023011B1 (nl) * | 2015-08-05 | 2016-11-04 | Nordic Specialty Pharma Bvba | Acetylsalicylzuur tablet met onmiddellijke afgifte |
ES2695503B2 (es) | 2017-06-30 | 2020-05-08 | Pharmalink S L | Formulaciones encapsuladas |
KR102042626B1 (ko) | 2019-06-26 | 2019-11-11 | 한미약품 주식회사 | 이베살탄 및 HMG-CoA 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제 |
EP4299063B1 (fr) | 2022-06-30 | 2024-05-01 | Ferrer Internacional, S.A. | Capsules à avaler comprenant des comprimés d'atorvastatine présentant un profil de dissolution et une biodisponibilité adaptés |
CN115671077A (zh) * | 2022-11-18 | 2023-02-03 | 乐普药业股份有限公司 | 一种预防心脑血管疾病的复方微丸胶囊及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3739690A1 (de) | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
JP2544052B2 (ja) * | 1991-12-18 | 1996-10-16 | 日本エランコ株式会社 | 硬質ゼラチンカプセルへの錠剤充填装置 |
SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
BRPI0108145B8 (pt) * | 2000-02-10 | 2021-05-25 | Bpsi Holdings Inc | composições de revestimento entérico acrílicas |
US6576256B2 (en) * | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
WO2004080488A2 (fr) * | 2003-03-10 | 2004-09-23 | Bayer Healthcare Ag | Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires |
CN1822820A (zh) * | 2003-07-28 | 2006-08-23 | 雷迪实验室有限公司 | 心血管疾病的治疗和预防 |
JP4680061B2 (ja) * | 2003-08-20 | 2011-05-11 | 塩野義製薬株式会社 | 新規コーティング組成物 |
US20070009591A1 (en) * | 2005-07-07 | 2007-01-11 | Trivedi Jay S | ACE inhibitor formulation |
US20070116756A1 (en) * | 2005-11-23 | 2007-05-24 | Dr. Reddy's Laboratories Limited | Stable pharmaceutical compositions |
US7427414B2 (en) * | 2006-01-18 | 2008-09-23 | Astron Research Limited | Modified release oral dosage form using co-polymer of polyvinyl acetate |
US20080014264A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
WO2009022821A2 (fr) | 2007-08-13 | 2009-02-19 | Hanall Pharmaceutical Company. Ltd | Préparation combinée contenant un inhibiteur de hmg-coa reductase et aspirine et son procédé d'élaboration |
-
2009
- 2009-03-25 KR KR1020107021681A patent/KR20110007602A/ko not_active Application Discontinuation
- 2009-03-25 HU HUE09724677A patent/HUE028919T2/en unknown
- 2009-03-25 CN CN2009801113235A patent/CN101980701A/zh active Pending
- 2009-03-25 PL PL09724677T patent/PL2273985T3/pl unknown
- 2009-03-25 CA CA2720800A patent/CA2720800C/fr active Active
- 2009-03-25 BR BRPI0909254A patent/BRPI0909254A2/pt not_active IP Right Cessation
- 2009-03-25 JP JP2011501225A patent/JP2011515445A/ja active Pending
- 2009-03-25 NZ NZ588239A patent/NZ588239A/en not_active IP Right Cessation
- 2009-03-25 RU RU2010144131/15A patent/RU2477123C2/ru active
- 2009-03-25 US US12/934,942 patent/US8753680B2/en active Active
- 2009-03-25 MX MX2010010479A patent/MX2010010479A/es active IP Right Grant
- 2009-03-25 EP EP09724677.1A patent/EP2273985B1/fr active Active
- 2009-03-25 ES ES09724677.1T patent/ES2569553T3/es active Active
- 2009-03-25 DK DK09724677.1T patent/DK2273985T3/en active
- 2009-03-25 SI SI200931435A patent/SI2273985T1/sl unknown
- 2009-03-25 AU AU2009228832A patent/AU2009228832A1/en not_active Abandoned
- 2009-03-25 UA UAA201011547A patent/UA99758C2/ru unknown
- 2009-03-25 WO PCT/EP2009/053545 patent/WO2009118359A2/fr active Application Filing
- 2009-03-26 TW TW098109878A patent/TW200944251A/zh unknown
- 2009-03-27 CL CL2009000767A patent/CL2009000767A1/es unknown
- 2009-03-27 AR ARP090101095A patent/AR071094A1/es not_active Application Discontinuation
- 2009-03-30 UY UY0001031741A patent/UY31741A/es unknown
-
2010
- 2010-09-27 NI NI201000159A patent/NI201000159A/es unknown
- 2010-09-27 GT GT201000275A patent/GT201000275A/es unknown
- 2010-09-28 SV SV2010003684A patent/SV2010003684A/es unknown
- 2010-09-29 HN HN2010001979A patent/HN2010001979A/es unknown
- 2010-10-03 IL IL208455A patent/IL208455A0/en unknown
- 2010-10-05 IS IS8932A patent/IS8932A/is unknown
- 2010-10-15 CR CR11736A patent/CR11736A/es not_active Application Discontinuation
- 2010-10-19 MA MA33268A patent/MA32347B1/fr unknown
- 2010-10-22 EC EC2010010562A patent/ECSP10010562A/es unknown
- 2010-10-28 CO CO10134210A patent/CO6311069A2/es not_active Application Discontinuation
-
2016
- 2016-04-20 HR HRP20160416TT patent/HRP20160416T1/hr unknown
- 2016-05-13 CY CY20161100410T patent/CY1117556T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32347B1 (fr) | Gelule pour la prévention de maladies cardiovasculaires | |
CY1123549T1 (el) | Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης | |
MA31606B1 (fr) | Anticorps anti-cd 79b immunoconjugues et procedes d'utilisation | |
MA37850A1 (fr) | Inhibiteurs de nep pour le traitement de maladies caractérisées par un agrandissement atrial ou une remodélisation atriale | |
MX2012003555A (es) | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. | |
MA34286B1 (fr) | Compositions pharmaceutiques et procédés pour les fabriquer | |
WO2006108582A3 (fr) | Genes marqueurs humains et agents de diagnostic, de traitement et de prophylaxie des troubles cardio-vasculaires et de l'atherosclerose | |
EA200970287A1 (ru) | Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты | |
ECSP088980A (es) | Composicion farmacéutica que comprende amlodipina y losartán | |
WO2007038459A3 (fr) | Composes de carboxyamine et leurs methodes d'utilisation | |
MA35513B1 (fr) | Compositions pharmaceutiques comprenant 40 - o - ( 2 - hydroxy) éthyl - rapamycine | |
MA33299B1 (fr) | Nouvelle formulation de naproxène | |
WO2011026125A3 (fr) | Compositions pharmaceutiques à rétention gastrique permettant une libération immédiate et prolongée d'acétaminophène | |
TW200833372A (en) | Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound | |
EA200701923A1 (ru) | Лекарственная форма для перорального введения витамина | |
WO2011151722A3 (fr) | Méthodes et compositions de traitement pharmaceutique par voie orale | |
MA34670B1 (fr) | Inhibiteurs de l'apoptose et leurs utilisations | |
WO2008112840A3 (fr) | Nouvelle composition et nouveaux procédés de traitement des maladies immunologiques | |
PL1778623T3 (pl) | Pochodne kwasów 1-fenyloalkanokarboksylowych do leczenia chorób neurodegeneracyjnych | |
NO20076663L (no) | Immunoglobuliner | |
UA96457C2 (ru) | Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением | |
MA62176A1 (fr) | Composition pharmaceutique contenant de l'acétominophène et de l'ibuprofène | |
UA94434C2 (ru) | Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит | |
BRPI0602206A (pt) | forma polimórfica de dexcetoprofeno trometamol, sua preparação e composições que a contêm | |
ATE508737T1 (de) | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung |